nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—Dacarbazine—muscle cancer	0.592	0.601	CbGbCtD
Clobetasol propionate—CYP1A2—Dacarbazine—muscle cancer	0.265	0.268	CbGbCtD
Clobetasol propionate—CYP1A2—Etoposide—muscle cancer	0.129	0.131	CbGbCtD
Clobetasol propionate—Telangiectasia—Methotrexate—muscle cancer	0.00086	0.0623	CcSEcCtD
Clobetasol propionate—Eruption—Dactinomycin—muscle cancer	0.00076	0.0551	CcSEcCtD
Clobetasol propionate—Folliculitis—Dactinomycin—muscle cancer	0.000743	0.0539	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—muscle cancer	0.000597	0.0433	CcSEcCtD
Clobetasol propionate—Leukoderma—Methotrexate—muscle cancer	0.000476	0.0345	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—muscle cancer	0.000421	0.0305	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—muscle cancer	0.000413	0.0299	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Methotrexate—muscle cancer	0.000341	0.0247	CcSEcCtD
Clobetasol propionate—Eruption—Methotrexate—muscle cancer	0.000329	0.0239	CcSEcCtD
Clobetasol propionate—Folliculitis—Methotrexate—muscle cancer	0.000322	0.0234	CcSEcCtD
Clobetasol propionate—Psoriasis—Methotrexate—muscle cancer	0.000322	0.0234	CcSEcCtD
Clobetasol propionate—Pain in extremity—Vincristine—muscle cancer	0.000303	0.022	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.000295	0.0214	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—muscle cancer	0.000285	0.0207	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—muscle cancer	0.000279	0.0202	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—muscle cancer	0.000279	0.0202	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—muscle cancer	0.00022	0.0159	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—muscle cancer	0.000216	0.0157	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—muscle cancer	0.000216	0.0157	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vincristine—muscle cancer	0.000209	0.0151	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—muscle cancer	0.000207	0.015	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vincristine—muscle cancer	0.000206	0.0149	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—muscle cancer	0.000204	0.0148	CcSEcCtD
Clobetasol propionate—Alopecia—Vincristine—muscle cancer	0.000185	0.0134	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—muscle cancer	0.000173	0.0126	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—muscle cancer	0.000169	0.0122	CcSEcCtD
Clobetasol propionate—Infection—Dactinomycin—muscle cancer	0.000166	0.012	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—muscle cancer	0.00015	0.0109	CcSEcCtD
Clobetasol propionate—Infection—Vincristine—muscle cancer	0.000148	0.0107	CcSEcCtD
Clobetasol propionate—Pain—Dactinomycin—muscle cancer	0.000143	0.0103	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—muscle cancer	0.000142	0.0103	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vincristine—muscle cancer	0.000134	0.0097	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—muscle cancer	0.000132	0.00958	CcSEcCtD
Clobetasol propionate—Pain—Vincristine—muscle cancer	0.000127	0.00923	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—muscle cancer	0.000127	0.00923	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000125	0.00906	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Dactinomycin—muscle cancer	0.000123	0.0089	CcSEcCtD
Clobetasol propionate—Infection—Etoposide—muscle cancer	0.00012	0.00869	CcSEcCtD
Clobetasol propionate—Skin disorder—Etoposide—muscle cancer	0.000117	0.0085	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—muscle cancer	0.000117	0.00846	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vincristine—muscle cancer	0.00011	0.00796	CcSEcCtD
Clobetasol propionate—Paraesthesia—Etoposide—muscle cancer	0.000108	0.00785	CcSEcCtD
Clobetasol propionate—Rash—Dactinomycin—muscle cancer	0.000105	0.00762	CcSEcCtD
Clobetasol propionate—Pain—Etoposide—muscle cancer	0.000103	0.00748	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—muscle cancer	9.93e-05	0.0072	CcSEcCtD
Clobetasol propionate—Rash—Vincristine—muscle cancer	9.39e-05	0.00681	CcSEcCtD
Clobetasol propionate—Dermatitis—Vincristine—muscle cancer	9.38e-05	0.0068	CcSEcCtD
Clobetasol propionate—Headache—Vincristine—muscle cancer	9.33e-05	0.00676	CcSEcCtD
Clobetasol propionate—Alopecia—Methotrexate—muscle cancer	8.99e-05	0.00652	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—muscle cancer	8.89e-05	0.00644	CcSEcCtD
Clobetasol propionate—Erythema—Methotrexate—muscle cancer	8.85e-05	0.00642	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—muscle cancer	8.76e-05	0.00635	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—muscle cancer	8.68e-05	0.00629	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—muscle cancer	8.66e-05	0.00627	CcSEcCtD
Clobetasol propionate—Pruritus—Etoposide—muscle cancer	8.54e-05	0.00619	CcSEcCtD
Clobetasol propionate—Alopecia—Doxorubicin—muscle cancer	7.78e-05	0.00564	CcSEcCtD
Clobetasol propionate—Erythema—Doxorubicin—muscle cancer	7.67e-05	0.00556	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—muscle cancer	7.61e-05	0.00551	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—muscle cancer	7.6e-05	0.00551	CcSEcCtD
Clobetasol propionate—Headache—Etoposide—muscle cancer	7.56e-05	0.00548	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	7.49e-05	0.00543	CcSEcCtD
Clobetasol propionate—Infection—Methotrexate—muscle cancer	7.18e-05	0.0052	CcSEcCtD
Clobetasol propionate—Skin disorder—Methotrexate—muscle cancer	7.02e-05	0.00509	CcSEcCtD
Clobetasol propionate—Paraesthesia—Methotrexate—muscle cancer	6.49e-05	0.0047	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	6.48e-05	0.0047	CcSEcCtD
Clobetasol propionate—Infection—Doxorubicin—muscle cancer	6.22e-05	0.00451	CcSEcCtD
Clobetasol propionate—Pain—Methotrexate—muscle cancer	6.18e-05	0.00448	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—muscle cancer	6.08e-05	0.00441	CcSEcCtD
Clobetasol propionate—Paraesthesia—Doxorubicin—muscle cancer	5.62e-05	0.00407	CcSEcCtD
Clobetasol propionate—Pain—Doxorubicin—muscle cancer	5.35e-05	0.00388	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Methotrexate—muscle cancer	5.32e-05	0.00386	CcSEcCtD
Clobetasol propionate—Pruritus—Methotrexate—muscle cancer	5.11e-05	0.00371	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Doxorubicin—muscle cancer	4.61e-05	0.00334	CcSEcCtD
Clobetasol propionate—Rash—Methotrexate—muscle cancer	4.56e-05	0.0033	CcSEcCtD
Clobetasol propionate—Dermatitis—Methotrexate—muscle cancer	4.55e-05	0.0033	CcSEcCtD
Clobetasol propionate—Headache—Methotrexate—muscle cancer	4.53e-05	0.00328	CcSEcCtD
Clobetasol propionate—Pruritus—Doxorubicin—muscle cancer	4.43e-05	0.00321	CcSEcCtD
Clobetasol propionate—Rash—Doxorubicin—muscle cancer	3.95e-05	0.00286	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—muscle cancer	3.94e-05	0.00286	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—muscle cancer	3.92e-05	0.00284	CcSEcCtD
